Buy Full Version
"World Patient Engagement Solutions Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

World Patient Engagement Solutions Market by Component - Opportunities and Forecasts, 2019-2026

High Tech, Enterprise & Consumer IT	IC_18915	Pages: NA	Dec 2019 \| 1935 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Patient engagement refers to anything that enables healthcare institutions to establish communication with their patients to using patient portal online. However, patient engagement is not just about engaging technology such as portal as well as automated messaging. Besides this, the process plays a vital role in ensuring patient satisfaction. On the other hand, the technology improves the service quality and ensures safety.

There are many drivers, restraints and opportunities that are influencing the patient engagement solutions market. Increasing awareness about mobile health, growing aging population as well as incentives provided by the government are responsible for driving the patient engagement market. However, absence of health literacy has hampered the market growth to a greater extent. Moreover, demand for value based drugs due to an increase in peer pressure and dramatic shift in patient specific solution would create greater opportunities.

The market is segmented based on components, delivery model, therapeutics, end-customer and geography. The key components assessed in the study includes hardware, software, consulting services and many more. Delivery model covered during the study are on premise, cloud and web. Therapeutics areas discussed in the report consists of fitness, diabetes, women health, obesity etc. Major end-customers of the market are payers, providers, patients and more. Regions such as North America, Europe, Asia -Pacific and LAMEA would experience rapid growth.

A closer look at the competitive landscape reveals that major IT brands are busy launching patient engagement solutions and generating clients in the same month itself. Prominent market players are also seen acquiring new companies or local market players to maintain their competitive edge. Other business strategies favored by the companies include constant upgradation, joint ventures and collaborations. Prominent brands active in the market are Orion Health, Emmi Solutions LLC., Allscripts Inc., Medecision Inc., Athenahealth, Inc. and others.

KEY BENEFITS FOR STAKEHOLDERS

The market research report provides an integrated information on the major drivers, restraints and opportunities influencing the industry growth during the forecast period.
The study further drills down to produce data volume by components, end customers and demography.
SWOT analysis of major brands, highlights weaknesses, strengths, opportunities and threats. The data proves effective for business owners planning on designing their marketing and branding strategies.
Region wise business performance discussed in the market research report would be valuable for enterprises planning to explore new areas.
The report not only examines the market dynamics but also takes a closer look at the growth rate and industrial chain structure.
Study further weigh up on the prominent market players and their business strategies to maintain their position.
Assessment of upstream and downstream market also forms an important part of the report.

PATIENT ENGAGEMENT SOLUTION MARKET KEY SEGMENTS

Patient Engagement Solutions Market By Component

Hardware
Software
Consulting Services
Others

Patient Engagement Solutions Market By Delivery Model

On -Premise
Web
Cloud

Patient Engagement Solutions Market By Therapeutics

Fitness,
Diabetes
Women Health
Obesity
Others

Patient Engagement Solutions Market By End Customers

Healthcare Providers
Patients
Payers
Others

Patient Engagement Solutions Market Geography

North America
Europe
Asia -Pacific
LAMEA
Key Market Players
Orion Health
Emmi Solutions LLC.
Allscripts Inc.
Medecision Inc.
Athenahealth, Inc.

1. INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tool & model

2. EXECUTIVE SUMMARY

2.1. CXO perspective

3. MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
3.2.1. Top factors impacting the market
3.2.2. Top investment pockets
3.2.3. Top winning strategies
3.3. Regulatory initiatives
3.4. Porter’s five force analysis
3.5. Market player positioning
3.6. Market dynamics
3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

4. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2017-2024 ($MILLION)

4.1. Market overview
4.2. Hardware
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. Software
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. Services
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

5. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017-2024 ($MILLION)

5.1. Market overview
5.2. On-premise
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.3. Cloud
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

6. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2017-2024 ($MILLION)

6.1. Market overview
6.2. Hospitals and healthcare providers
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.3. Healthcare payers
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.4. Individual users
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.5. Others
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

7. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2017-2024 ($MILLION)

7.1. Market overview
7.2. Health management
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.3. Home health management
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.4. Financial health management
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.5. Social and behavioral management
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.6. Others
7.6.1. Key market trends
7.6.2. Key growth factors and opportunities
7.6.3. Market size and forecast

8. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2017-2024 ($MILLION)

8.1. Market overview
8.2. Chronic diseases
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.3. Women’s health
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.4. Fitness
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.5. Others
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

9. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2017-2024 ($MILLION)

9.1. Market overview
9.2. North America
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast by
9.2.3.1. Component
9.2.3.2. Deployment mode
9.2.3.3. End user
9.2.3.4. Application
9.2.3.5. Therapeutic area
9.2.3.6. Country
9.2.3.6.1. U.S.
9.2.3.6.1.1. Market size and forecast, by component
9.2.3.6.1.2. Market size and forecast, by deployment mode
9.2.3.6.1.3. Market size and forecast, by end user
9.2.3.6.1.4. Market size and forecast, by application
9.2.3.6.1.5. Market size and forecast, by therapeutic area
9.2.3.6.2. Canada
9.2.3.6.2.1. Market size and forecast, by component
9.2.3.6.2.2. Market size and forecast, by deployment mode
9.2.3.6.2.3. Market size and forecast, by end user
9.2.3.6.2.4. Market size and forecast, by application
9.2.3.6.2.5. Market size and forecast, by therapeutic area
9.2.3.6.3. Mexico
9.2.3.6.3.1. Market size and forecast, by component
9.2.3.6.3.2. Market size and forecast, by deployment mode
9.2.3.6.3.3. Market size and forecast, by end user
9.2.3.6.3.4. Market size and forecast, by application
9.2.3.6.3.5. Market size and forecast, by therapeutic area
9.3. Europe
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast by
9.3.3.1. Component
9.3.3.2. Deployment mode
9.3.3.3. End user
9.3.3.4. Application
9.3.3.5. Therapeutic area
9.3.3.6. Country
9.3.3.6.1. UK
9.3.3.6.1.1. Market size and forecast, by component
9.3.3.6.1.2. Market size and forecast, by deployment mode
9.3.3.6.1.3. Market size and forecast, by end user
9.3.3.6.1.4. Market size and forecast, by application
9.3.3.6.1.5. Market size and forecast, by therapeutic area
9.3.3.6.2. Germany
9.3.3.6.2.1. Market size and forecast, by component
9.3.3.6.2.2. Market size and forecast, by deployment mode
9.3.3.6.2.3. Market size and forecast, by end user
9.3.3.6.2.4. Market size and forecast, by application
9.3.3.6.2.5. Market size and forecast, by therapeutic area
9.3.3.6.3. France
9.3.3.6.3.1. Market size and forecast, by component
9.3.3.6.3.2. Market size and forecast, by deployment mode
9.3.3.6.3.3. Market size and forecast, by end user
9.3.3.6.3.4. Market size and forecast, by application
9.3.3.6.3.5. Market size and forecast, by therapeutic area
9.3.3.6.4. Rest of Europe
9.3.3.6.4.1. Market size and forecast, by component
9.3.3.6.4.2. Market size and forecast, by deployment mode
9.3.3.6.4.3. Market size and forecast, by end user
9.3.3.6.4.4. Market size and forecast, by application
9.3.3.6.4.5. Market size and forecast, by therapeutic area
9.4. Asia-Pacific
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size and forecast by
9.4.3.1. Component
9.4.3.2. Deployment mode
9.4.3.3. End user
9.4.3.4. Application
9.4.3.5. Therapeutic area
9.4.3.6. Country
9.4.3.6.1. China
9.4.3.6.1.1. Market size and forecast, by component
9.4.3.6.1.2. Market size and forecast, by deployment mode
9.4.3.6.1.3. Market size and forecast, by end user
9.4.3.6.1.4. Market size and forecast, by application
9.4.3.6.1.5. Market size and forecast, by therapeutic area
9.4.3.6.2. India
9.4.3.6.2.1. Market size and forecast, by component
9.4.3.6.2.2. Market size and forecast, by deployment mode
9.4.3.6.2.3. Market size and forecast, by end user
9.4.3.6.2.4. Market size and forecast, by application
9.4.3.6.2.5. Market size and forecast, by therapeutic area
9.4.3.6.3. Japan
9.4.3.6.3.1. Market size and forecast, by component
9.4.3.6.3.2. Market size and forecast, by deployment mode
9.4.3.6.3.3. Market size and forecast, by end user
9.4.3.6.3.4. Market size and forecast, by application
9.4.3.6.3.5. Market size and forecast, by therapeutic area
9.4.3.6.4. Rest of Asia-Pacific
9.4.3.6.4.1. Market size and forecast, by component
9.4.3.6.4.2. Market size and forecast, by deployment mode
9.4.3.6.4.3. Market size and forecast, by end user
9.4.3.6.4.4. Market size and forecast, by application
9.4.3.6.4.5. Market size and forecast, by therapeutic area
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast by
9.5.3.1. Component
9.5.3.2. Deployment mode
9.5.3.3. End user
9.5.3.4. Application
9.5.3.5. Therapeutic area
9.5.3.6. Country
9.5.3.6.1. Latin America
9.5.3.6.1.1. Market size and forecast, by component
9.5.3.6.1.2. Market size and forecast, by deployment mode
9.5.3.6.1.3. Market size and forecast, by end user
9.5.3.6.1.4. Market size and forecast, by application
9.5.3.6.1.5. Market size and forecast, by therapeutic area
9.5.3.6.2. Middle East
9.5.3.6.2.1. Market size and forecast, by component
9.5.3.6.2.2. Market size and forecast, by deployment mode
9.5.3.6.2.3. Market size and forecast, by end user
9.5.3.6.2.4. Market size and forecast, by application
9.5.3.6.2.5. Market size and forecast, by therapeutic area
9.5.3.6.3. Africa
9.5.3.6.3.1. Market size and forecast, by component
9.5.3.6.3.2. Market size and forecast, by deployment mode
9.5.3.6.3.3. Market size and forecast, by end user
9.5.3.6.3.4. Market size and forecast, by application
9.5.3.6.3.5. Market size and forecast, by therapeutic area

10. COMPANY PROFILES

10.1. Cisco Systems, Inc.
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Business performance
10.1.4. Operating business segments
10.1.5. Key strategies and developments
10.2. Mckesson Corporation
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Business performance
10.2.4. Operating business segments
10.2.5. Key strategies and developments
10.3. Welvu, Inc.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Business performance
10.3.4. Operating business segments
10.3.5. Key strategies and developments
10.4. Get Real Health
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Business performance
10.4.4. Operating business segments
10.4.5. Key strategies and developments
10.5. EMMI Solutions, LLC
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Business performance
10.5.4. Operating business segments
10.5.5. Key strategies and developments
10.6. GetWellNetwork Inc
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Business performance
10.6.4. Operating business segments
10.6.5. Key strategies and developments
10.7. Phytel, Inc.
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Business performance
10.7.4. Operating business segments
10.7.5. Key strategies and developments
10.8. Mckesson Corporation
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Business performance
10.8.4. Operating business segments
10.8.5. Key strategies and developments
10.9. Allscripts Healthcare Solutions
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Business performance
10.9.4. Operating business segments
10.9.5. Key strategies and developments
10.10. Athenahealth, Inc.
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Business performance
10.10.4. Operating business segments
10.10.5. Key strategies and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,110 Data Pack/Excel ~~$3,840~~ $3,456 Single User License ~~$5,370~~ $4,833 Five User License ~~$6,450~~ $5,805 Enterprise User License ~~$8,995~~ $8,096

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285, Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry